Norway - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingNorway: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024
Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Norway
The Norwegian prophylactic medicaments containing insulin market fell slightly to $X in 2022, approximately mirroring the previous year. The market value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the market attained the maximum level at $X in 2017; however, from 2018 to 2022, consumption stood at a somewhat lower figure.
Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Norway
In value terms, prophylactic medicaments containing insulin production reduced modestly to $X in 2022 estimated in export price. Over the period under review, the total production indicated a noticeable increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production increased by X% against 2020 indices. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, production reached the peak level at $X in 2017; however, from 2018 to 2022, production remained at a lower figure.
Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Exports from Norway
In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the second consecutive year after six years of decline. Over the period under review, exports, however, faced a abrupt contraction. The exports peaked at X tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.
In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. Overall, exports, however, continue to indicate a dramatic decline. The exports peaked at $X in 2014; however, from 2015 to 2022, the exports failed to regain momentum.
Exports by Country
Poland (X kg) was the main destination for prophylactic medicaments containing insulin exports from Norway, accounting for a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Poland exceeded the volume sent to the second major destination, Slovakia (X kg), twofold.
From 2012 to 2022, the average annual growth rate of volume to Poland was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Slovakia (X% per year) and Germany (X% per year).
In value terms, Poland ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Norway, comprising X% of total exports. The second position in the ranking was taken by Slovakia ($X), with a X% share of total exports.
From 2012 to 2022, the average annual rate of growth in terms of value to Poland was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Slovakia (X% per year) and Germany (X% per year).
Export Prices by Country
The average prophylactic medicaments containing insulin export price stood at $X per kg in 2022, waning by X% against the previous year. In general, the export price continues to indicate a abrupt slump. The most prominent rate of growth was recorded in 2019 an increase of X% against the previous year. The export price peaked at $X per kg in 2013; however, from 2014 to 2022, the export prices failed to regain momentum.
There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Germany ($X per kg), while the average price for exports to Slovakia ($X per kg) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (X%), while the prices for the other major destinations experienced mixed trend patterns.
Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Imports into Norway
Prophylactic medicaments containing insulin imports into Norway declined sharply to X tons in 2022, which is down by X% compared with the previous year. Over the period under review, imports saw a deep contraction. The most prominent rate of growth was recorded in 2019 with an increase of X%. Over the period under review, imports attained the maximum at X tons in 2015; however, from 2016 to 2022, imports failed to regain momentum.
In value terms, prophylactic medicaments containing insulin imports declined to $X in 2022. Overall, imports faced a abrupt curtailment. The most prominent rate of growth was recorded in 2021 with an increase of X%. Imports peaked at $X in 2012; however, from 2013 to 2022, imports remained at a lower figure.
Imports by Country
Denmark (X tons), Germany (X tons) and the Czech Republic (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Norway, together accounting for X% of total imports.
From 2012 to 2022, the biggest increases were recorded for the Czech Republic (with a CAGR of X%), while purchases for the other leaders experienced a decline.
In value terms, the largest prophylactic medicaments containing insulin suppliers to Norway were Denmark ($X), Germany ($X) and the Czech Republic ($X), with a combined X% share of total imports.
In terms of the main suppliers, the Czech Republic, with a CAGR of X%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.
Import Prices by Country
The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, increasing by X% against the previous year. In general, import price indicated a mild increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price increased by X% against 2020 indices. The pace of growth appeared the most rapid in 2018 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2019 to 2022, the average import prices remained at a lower figure.
Average prices varied somewhat amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the Czech Republic ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Germany (X%), while the prices for the other major suppliers experienced mixed trend patterns.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Norway. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- Norway
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Norway
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
- Price for Prophylactic Medicaments Containing Insulin Norway
- Prophylactic Medicaments Containing Insulin Market
- Chemically Modified Oils Market
- Crude Glycerol Market
- Salicylic Acid Market
- O-acetylsalicylic Acid Market
- Esters of Salicylic Acid and Their Salts Market
- Lysine Market
- Glutamic Acid Market
- Quaternary Ammonium Salts and Hydroxides Market